ERBB2 and breast cancer: To study the effect of ASCs on early metastasis, this study used the human MDA-MB-231 breast cancer model which does not express estrogen receptor (ER), progesterone receptor (PR) or Her2 [47] and represents a model of “triple negative” breast cancer in patients, a more aggressive and metastatic breast cancer subtype.